Australian Prescriber

Australian Prescriber is an independent peer-reviewed journal providing critical commentary on drugs and therapeutics for health professionals.

SUBSCRIBE TO AUSTRALIAN PRESCRIBER

Subscribe to receive email updates when new Australian Prescriber articles are published

Subscribe now

  • Volume 45 Issue 5

  • October 2022

Treating osteoporosis: risks and management

Treating osteoporosis: risks and management
Article
Jimmy Zhu, Lyn March
  • 4 October 2022
  • Podcast - Treating osteoporosis: risks and management

Given the high prevalence of osteoporosis, many cases are likely to be undetected and undertreated.
Article

Erectile dysfunction: causes, assessment and management options

Erectile dysfunction: causes, assessment and management options
Article

Erectile dysfunction: causes, assessment and management options

Michael Lowy, Vijayasarathi Ramanathan
  • 4 October 2022
  • Podcast - Erectile dysfunction: causes, assessment and management options

When recommending a phosphodiesterase-5 inhibitor, it is essential to discuss the likely effects as patients can have unrealistic expectations.
Article

Bariatric surgery and medicines: from first principles to practice

Bariatric surgery and medicines: from first principles to practice
Article

Bariatric surgery and medicines: from first principles to practice

Teresa Girolamo, Rosemary Allin
  • 4 October 2022

A growing number of patients with obesity are having bariatric surgery. Find out how this affects drug absorption.
Article

Drug management of autosomal dominant polycystic kidney disease

Drug management of autosomal dominant polycystic kidney disease
Article

Drug management of autosomal dominant polycystic kidney disease

Thiveya Theivendran, Alister Ramachandran, Gopi Rangan
  • 4 October 2022
  • Podcast - Drug management of autosomal dominant polycystic kidney disease

Article

Drug treatment of cystic fibrosis

Cystic-fibrosis-Getty Images-637854520-resized
Article

Drug treatment of cystic fibrosis

Matthew Bruorton, Thomas Goddard
  • 4 October 2022
Letters to the Editor

Role of empagliflozin in chronic lithium toxicity

Lithium-toxicity-Getty Images-1352489941
Letters to the Editor

Role of empagliflozin in chronic lithium toxicity

Vicki Dyson, Ian Whyte, Frank Reimann
  • 4 October 2022
Correction

Approach to the diagnosis of secondary hypertension in adults [Correction]

Secondary-hypertension-Getty Images-943375326
Correction

Approach to the diagnosis of secondary hypertension in adults [Correction]

  • 4 October 2022
Correction

Trifarotene for acne [Correction]

Trifarotene-for-acne-Getty Images-141571823
Correction

Trifarotene for acne [Correction]

  • 4 October 2022

New drugs

Amifampridine for Lambert-Eaton myasthenic syndrome

  • 4 October 2022

Anifrolumab for systemic lupus erythematosus

  • 4 October 2022

Bilastine for allergic rhinoconjunctivitis, urticaria

  • 4 October 2022

Diroximel fumarate for multiple sclerosis

  • 4 October 2022

Somatrogon for growth hormone deficiency

  • 4 October 2022

Tixagevimab and cilgavimab for COVID-19 prophylaxis

  • 4 October 2022

Early release

Correction

Bariatric surgery and medicines [Correction]

  • 21 October 2022
New drug

Elasomeran/imelasomeran for prevention of COVID-19

  • 12 October 2022
New drug

Asciminib for chronic myeloid leukaemia

  • 12 October 2022
New drug

Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes

  • 12 October 2022
New drug

Selinexor for multiple myeloma

  • 12 October 2022

SUBSCRIBE TO AUSTRALIAN PRESCRIBER

Subscribe to receive email updates when new Australian Prescriber articles are published

Subscribe now
Online tool
Doctors Bag Hero